- Liquid biopsy company Angle detailed plans for a conditional equity placing to raise gross proceeds of up to £20 million.

The company proposed to place 43,478,261 shares at a price of 46 pence per share, representing a discount of approximately 5.15% to the closing mid-market price of 48.5 pence on 26 October 2020.

The company said it would use the £7 million of the proceeds for ongoing operations, £5m to establishing clinical laboratories for pharma services and laboratory developed test, £5m for the parsortix assay development and clinical studies, and £6m for commercial expansion including reimbursement, sales and partnerships.

At 9:58am: [LON:AGL] Angle PLC share price was +1.3p at 49.8p

Story provided by